Table 2.

The relationship between the CSN1S1 and the clinicopathological characteristics of breast cancer using TCGA.

Parameters	mRNA expression	n	p-value
SampleType
Normal	↑	114
Primary tumor	↓	1097	0.51
PatientsRace
Normal	↑	114
Caucasian	↓	745	0.83
African -american	↓	179	0.05
Asian	↓	61	0.05
Cancer Stages
Normal	↑	114
Stage 1	↓	153	0.87
Stage 2	↓	615	0.68
Stage 3	↓	247	0.04
Stage 4	↓	20	0.04
Cancer Subclasses
Normal	↑	114
Luminal	↓	566	0.74
HER2 positive	↓	37	0.04
Triple negative	↓	116	0.65
Patient's Gender
Normal	↑	114
Male	↓	12	0.04
Female	↓	1075	0.52
Patient's Age
Normal	↑	114
21–40	↓	97	0.58
41–60	↓	505	0.83
61–80	↓	431	0.05
81–100	↓	54	0.04
Menopause Status
Normal	↑	114
Pre-menopause	↓	230	4.04E-01
Peri-menopause	↓	37	4.33E-02
Post- menopause	↓	700	4.44E-02